Digene Corp., a Gaithersburg-based maker of diagnostic tests, announced yesterday the termination of its merger with Cytyc Corp. The decision was widely expected after the Federal Trade Commission ...

Digene Corp. of Gaithersburg will pay a New York biotechnology company at least $30.5 million to settle a patent-infringement lawsuit involving technology used in its leading product, the only ...

Without having to expand or even reposition our current marketing and sale structure, we can take this product and fold it right in.”Cystic fibrosis affects one in 2,500 to 3,300 live births, ...

The Gaithersburg company that makes the only approved test for the virus that causes cervical cancer is taking its message out of doctors’ offices and into homes nationwide. Digene Corp. is launching ...

Digene Gel is an over-the-counter antacid medication used to relieve symptoms associated with acidity, heartburn, and indigestion. This type of antacid is taken orally and works by neutralizing excess ...

Qiagen, a Dutch manufacturer of genetic testing equipment, announced Sunday it will purchase Digene Corp. for $1.6 billion in cash and stock. Digene produces DNA and RNA screening tests for cervical ...

QIAGEN N.V. has announced the successful completion of its acquisition of Digene Corporation. QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a ...

Abbott India has recently recalled its Digene Gel product from the market after the Drug Controller General of India (DCGI) issued an advisory against its sale. Drug Controller General of India (DCGI) ...

Shares of Digene, a maker of DNA and RNA tests, sizzled on Monday after it announced that Netherlands-based Qiagen would purchase the company in a $1.6 billion deal. Digene is best known for a test to ...

When federal regulators last week approved Digene Corp.'s cervical cancer test as a primary screening tool for women over 30, they catapulted what had been a follow-up test into direct competition ...

Digene Corp. announced yesterday that Daryl J. Faulkner, a biotech industry veteran, will take over as chief executive next month. Faulkner replaces the Gaithersburg company’s current CEO, Evan L.

The diagnostic firm Digene Corp. is raising $56 million in gross proceeds by way of a public offering announced after Wednesday's market close. Management at the Gaithersburg, Md.-based company ...